Searchable abstracts of presentations at key conferences in endocrinology

ea0081p181 | Reproductive and Developmental Endocrinology | ECE2022

Hormonal treatment modification during the long term follow-up of transwomen and transmen individuals: a retrospective observational Italian study

Cacciani Marta , Spaggiari Giorgia , M. Granata Antonio R. , Simoni Manuela , Santi Daniele

Background: Persons with assigned either male (AMAB) or female (AFAB) sex at birth might wish to obtain feminization or masculinization, respectively. To this purpose, hormonal treatment with sex hormones must be tailored to each subject. Several studies and the European Society of Endocrinology guidelines tried to identify the optimal hormonal treatment in both AMAB and AFAB subjects. However, the clinical management in the long term follow-up remains challenging. Many treatm...

ea0081ep851 | Reproductive and Developmental Endocrinology | ECE2022

Eunuchoid skeletal proportions in male hypogonadism: a comparative analysis of anthropometric measures between men with congenital hypogonadotropic hypogonadism (CHH) and Klinefelter Syndrome (KS)

De Vincentis Sara , Corleto Rossella , Bellelli Alessio , Zirilli Lucia , Santamaria Emanuele , Granata Antonio , Rochira Vincenzo

Background: Patients with CHH and KS have eunuchoid body proportions of the skeleton compared to normal male subjects, characterized by tall stature, and reduced upper-to-lower segment ratio (U/l). Vice versa, steroids exposure deeply differs between CHH and KS at puberty, with both testosterone and estradiol being very low only in CHH. At present, body skeletal proportions comparison between CHH and KS is not available.Aim: To compare anthropom...

ea0081ep867 | Reproductive and Developmental Endocrinology | ECE2022

Real-world evidence of follicle stimulating hormone effectiveness in male idiophatic infertility

Romeo Marilina , Spaggiari Giorgia , Nuzzo Federico , R.M. Granata Antonio , Simoni Manuela , Santi Daniele

Introduction: Male idiopathic infertility represents a therapeutic challenge for physicians, since a targeted aetiological treatment does not exist. Several hormonal and non-hormonal therapies have been proposed so far to increase pregnancy rates. Among hormonal therapies, exogenous follicle-stimulating hormone (FSH) administration shows the most convincing physiological rationale in the face of a clinical efficacy below expectations. Indeed, from evidences available in the li...

ea0081ep896 | Reproductive and Developmental Endocrinology | ECE2022

Vascular erectile dysfunction as a mirror of general health: focus on patients comorbidities

Rossi Barbara , Romeo Marilina , Granata Antonio Raffaele Michele , Rochira Vincenzo , Simoni Manuela , Spaggiari Giorgia , Santi Daniele

Background: Erectile dysfunction (ED) represents the most frequent sexual dysfunction. Among several possible ED aetiologies, vascular ED (vED) presents the greatest implications for global individual health, resulting an early hallmark of cardiovascular diseases. Indeed, vED was demonstrated associated with a 1.25 times greater risk of developing major cardiovascular diseases. Alongside cardiovascular aspect, the evaluation of patients health, measured by the comorbidities nu...

ea0083rdo1 | Reproductive and Developmental Endocrinology | EYES2022

Follicle stimulating hormone is efficient in increasing sperm parameters in idiopathic infertility

M. Romeo , G Spaggiari , F Nuzzo , A. R. Granata , M. Simoni , D. Santi

Background: Exogenous follicle-stimulating hormone (FSH) administration in male idiopathic infertility showed the most convincing rationale in the face of a clinical efficacy below expectations. It was calculated that 10 to 18 men have to be treated to achieve one pregnancy.Objectives: To assess the effectiveness of FSH administration in male idiopathic infertility in a clinical setting.Methods: A retrospective real-world study was...

ea0083rdo4 | Reproductive and Developmental Endocrinology | EYES2022

Comparison of eunuchoid skeletal proportions in male hypogonadism between men with congenital hypogonadotropic hypogonadism (CHH) and Klinefelter Syndrome (KS)

A. Bellelli , S. De Vincentis , R. Corleto , L Zirilli , E Santamaria , A Granata , V. Rochira

Background: Patients with CHH and KS share eunuchoid body proportions of skeleton compared to normal male subjects. On the contrary, testosterone levels at puberty are lower in CHH patients compared to KS patients.Aim: To compare anthropometric measurements of adult male CHH vs KS patients.Methods: A prospective, cross-sectional, observational study was conducted. CHH patients were subdivided into 2 subgroups according to the timin...

ea0083rdo5 | Reproductive and Developmental Endocrinology | EYES2022

Vascular erectile dysfunction as a mirror of general health: focus on patients comorbidities

B. Rossi , M. Romeo , A. R. Granata , V. Rochira , M. Simoni , G Spaggiari , D. Santi

Background: Erectile dysfunction (ED) is the most frequent sexual disorder. Although psychological ED (pED) is the most frequent form, vascular ED (vED) is associated with 1.25 times greater risk of developing major cardiovascular diseases. Alongside cardiovascular aspect, the evaluation of patients’ health, measured by the comorbidities number, in relation to the ED aetiology has never been investigated so far.Objectives: To explore the potential r...

ea0067o53 | Oral Presentations | EYES2019

Seasonal changes of serum gonadotropins and testosterone in men: a reappraisal from a large data set of real-world observations over eight years

Spaggiari Giorgia , Granata Antonio RM , Setti Monica , Tagliavini Simonetta , Trenti Tommaso , Simoni Manuela , Santi Daniele

Objective: Environmental rhythmicity seems able to affect the hypothalamic-pituitary-gonadal axis in animals, but the extent of its influence in humans is still controversial. This study was designed to evaluate seasonal fluctuations of the main hormones involved in the hypothalamic-pituitary-gonadal axis in men, using a big data approach.Methods: An observational, retrospective, big data trial was carried out, including all testosterone, luteinizing hor...

ea0049oc11.1 | Obesity | ECE2017

Role of Extracellular vesicles in the crosstalk between adipocytes and pancreatic beta-cells

Gesmundo Iacopo , Gargantini Eleonora , Favaro Enrica , Piemonti Lorenzo , Camussi Giovanni , Granata Riccarda

Obesity is characterized by insulin resistance and pancreatic β-cell dysfunction; moreover, secretion of adipokines from adipocytes may affect metabolic functions in several tissues, including pancreatic β-cells. Extracellular vesicles (EVs), released by cells as exosomes or shedding vesicles, play a key role in cell-to-cell communication, modifying the phenotype and function of recipient cells by delivering proteins, RNAs and microRNAs. The crosstalk between adipocy...

ea0049gp151 | Neuroendocrinology & Growth Hormones | ECE2017

Growth hormone-releasing hormone (GHRH) antagonists, MIA-602 and MIA-690, inhibit survival and proliferation of human pleural mesothelioma cells

Villanova Tania , Gesmundo Iacopo , Taliano Marina , Ghigo Ezio , Schally Andrew V , Granata Riccarda

Human malignant pleural mesothelioma (MPM) is a rare but aggressive neoplasm, arising from pleural mesothelial cells, generally due to asbestos exposure. Different growth factors are involved in the pathogenesis of MPM and in resistance to therapy; moreover, chemotherapy with cisplatin and antifolates, like pemetrexed (PEM), is the first-line treatment for inoperable MPM. Growth hormone-releasing hormone (GHRH), apart from stimulating GH secretion in the pituitary, exerts many...